HYOSUNG CHEMICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56,700 KRW | +0.53% |
|
+2.16% | -34.07% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 459,191 | 497,325 | 964,461 | 316,191 | 325,035 | 214,297 | - | - |
| Enterprise Value (EV) 2 | 1,749 | 2,102 | 2,967 | 2,759 | 325 | 2,346 | 2,374 | 2,449 |
| P/E ratio | 5.23 x | -42.8 x | 13.7 x | -0.77 x | -0.81 x | -1.86 x | 3.64 x | 1.02 x |
| Yield | 3.46% | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.25 x | 0.27 x | 0.39 x | 0.11 x | 0.12 x | 0.07 x | 0.07 x | 0.07 x |
| EV / Revenue | 0.97 x | 1.16 x | 1.21 x | 0.96 x | 0.12 x | 0.8 x | 0.74 x | 0.79 x |
| EV / EBITDA | 5.62 x | 8.84 x | 8.6 x | -56.5 x | 5.76 x | 13.5 x | 5.47 x | 4.34 x |
| EV / FCF | -5.51 x | -5.43 x | -11.4 x | -7.11 x | - | -11.7 x | 9.62 x | 8.36 x |
| FCF Yield | -18.2% | -18.4% | -8.75% | -14.1% | - | -8.52% | 10.4% | 12% |
| Price to Book | 1.01 x | 1.24 x | 1.93 x | 2.77 x | - | 0.72 x | -35.5 x | 3.26 x |
| Nbr of stocks (in thousands) | 3,178 | 3,178 | 3,178 | 3,178 | 3,779 | 3,779 | - | - |
| Reference price 3 | 144,500 | 156,500 | 303,500 | 99,500 | 86,000 | 56,700 | 56,700 | 56,700 |
| Announcement Date | 1/31/20 | 1/29/21 | 1/26/22 | 1/30/23 | 1/29/24 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,812 | 1,817 | 2,453 | 2,879 | 2,792 | 2,946 | 3,214 | 3,115 |
| EBITDA 1 | 311.2 | 237.9 | 344.9 | -48.85 | 56.43 | 174 | 434 | 564 |
| EBIT 1 | 153.9 | 60.93 | 148.6 | -336.7 | -188.8 | -47 | 156.9 | 276 |
| Operating Margin | 8.49% | 3.35% | 6.06% | -11.7% | -6.76% | -1.6% | 4.88% | 8.86% |
| Earnings before Tax (EBT) 1 | 110 | 3.421 | 114.4 | -448.2 | -371.9 | -134 | 73.55 | 230 |
| Net income 1 | 87.82 | -11.62 | 70.41 | -408.9 | -346.9 | -115 | 59.25 | 210 |
| Net margin | 4.85% | -0.64% | 2.87% | -14.2% | -12.43% | -3.9% | 1.84% | 6.74% |
| EPS 2 | 27,637 | -3,656 | 22,158 | -128,664 | -106,721 | -30,557 | 15,592 | 55,514 |
| Free Cash Flow 3 | -317,640 | -387,417 | -259,605 | -387,952 | - | -200,000 | 246,700 | 293,000 |
| FCF margin | -17,525.23% | -21,319.57% | -10,583.2% | -13,477.3% | - | -6,788.87% | 7,676.51% | 9,406.1% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 56,849.87% | 51,950.35% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 416,371.31% | 139,523.81% |
| Dividend per Share | 5,000 | - | - | - | - | - | - | - |
| Announcement Date | 1/31/20 | 1/29/21 | 1/26/22 | 1/30/23 | 1/29/24 | - | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 630.6 | 612 | 727.2 | 766.4 | 702.9 | 682.1 | 669.5 | 711.7 | 686.5 | 744 | 743 | 716 | 744 |
| EBITDA | 77.03 | 42.74 | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 32.89 | -16.76 | -33.17 | -68.08 | -139.8 | -95.71 | - | - | -37.46 | -69 | -37 | 18 | 42 |
| Operating Margin | 5.22% | -2.74% | -4.56% | -8.88% | -19.89% | -14.03% | - | - | -5.46% | -9.27% | -4.98% | 2.51% | 5.65% |
| Earnings before Tax (EBT) 1 | 24.14 | -27.38 | -50.52 | -86.91 | -171.1 | -139.8 | - | - | -85.45 | -90 | -56 | -4 | 16 |
| Net income 1 | 14 | -32.3 | -49.58 | -87.7 | -151.8 | -119.8 | - | -48.03 | -74.11 | -78 | -48 | -3 | 14 |
| Net margin | 2.22% | -5.28% | -6.82% | -11.44% | -21.6% | -17.56% | - | -6.75% | -10.79% | -10.48% | -6.46% | -0.42% | 1.88% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/29/21 | 1/26/22 | 4/27/22 | 7/29/22 | 10/28/22 | 1/30/23 | 5/12/23 | 10/27/23 | 1/29/24 | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,290 | 1,605 | 2,003 | 2,443 | - | 2,132 | 2,160 | 2,235 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.145 x | 6.747 x | 5.807 x | -50 x | - | 12.25 x | 4.976 x | 3.963 x |
| Free Cash Flow 2 | -317,640 | -387,417 | -259,605 | -387,952 | - | -200,000 | 246,700 | 293,000 |
| ROE (net income / shareholders' equity) | 21.4% | -2.71% | 15.6% | -135% | -393% | -50.1% | 60.8% | - |
| ROA (Net income/ Total Assets) | 4.73% | -0.52% | 2.57% | -13.2% | - | -3% | 1.85% | 6.1% |
| Assets 1 | 1,858 | 2,240 | 2,737 | 3,088 | - | 3,833 | 3,203 | 3,443 |
| Book Value Per Share 3 | 143,089 | 126,614 | 157,190 | 35,929 | - | 78,997 | -1,595 | 17,390 |
| Cash Flow per Share | 51,372 | 52,974 | 21,608 | -63,223 | - | - | - | - |
| Capex 1 | 481 | 556 | 328 | 190 | - | 115 | 93 | 264 |
| Capex / Sales | 26.53% | 30.58% | 13.38% | 6.59% | - | 3.9% | 2.89% | 8.48% |
| Announcement Date | 1/31/20 | 1/29/21 | 1/26/22 | 1/30/23 | 1/29/24 | - | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
56,700
KRW
Average target price
95,000
KRW
Spread / Average Target
+67.55%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -34.07% | 156M | |
| +5.14% | 103B | |
| -5.63% | 63.04B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.41% | 33.26B | |
| +6.85% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
- Stock Market
- Equities
- A298000 Stock
- Financials Hyosung Chemical Corporation
